The Senate on Thursday gave the green light to President Obama to transfer the accused plotters of the...
unaggregatedarticle
Science Editor LOS ANGELES - Two studies presented at the American Association for Cancer Research annual meeting are...
unaggregatedarticle
Staff Writer Vion Pharmaceuticals Inc. decided to move one lead cancer drug into pivotal trials, while expanding the...
unaggregatedarticle
Nov. 3--Testing a new drug on patients used to be done at universities, which could count on hundreds...
unaggregatedarticle
Nov. 3--Testing a new drug on patients used to be done at universities, which could count on hundreds...
unaggregatedarticle
Testing a new drug on patients used to be done at universities, which could count on hundreds of...
unaggregatedarticle
For many cancer patients, clinical trials of new treatments and drugs offer hope of a better quality of...
unaggregatedarticle
Staff Writer Global development of YM BioSciences Inc. 's nimotuzumab continued to advance with the start of two...
unaggregatedarticle
Staff Writer Bioenvision Inc. completed a private placement, raising $17.75 million to be used for clinical trials of...
unaggregatedarticle
West Coast Editor In the wake of mixed study results disclosed at a scientific meeting, the refusal of...
unaggregatedarticle
Staff Writer With the apoptosis drug AT-101 in several Phase II cancer trials, Ascenta Therapeutics Inc. raised $50...
unaggregatedarticle
Genzyme Corporation ( NASDAQ: GENZ ) announced that the company has begun enrollment in the first of two...
unaggregatedarticle
Senior Staff Writer Following last week's American Society of Clinical Oncology meeting, at which it learned of toxicities...
unaggregatedarticle
Staff Writer InSite Vision Inc. initiated patient enrollment in two Phase III trials of its lead drug, AzaSite,...
unaggregatedarticle
Ironwood Pharmaceuticals Inc (Ironwood) and Forest Laboratories Inc announced positive top-line results from two Phase III clinical trials...
unaggregatedarticle
Byline: Brian Collins WASHINGTON-Tens of thousand of borrowers in trial loan modifications - possibly more - are unlikely...
unaggregatedarticle
Staff Writer Less than three weeks after kicking off a Phase III program for VEGF Trap-Eye in wet...
unaggregatedarticle
CORPORATE IT UPDATE-(C)1995-2009 M2 COMMUNICATIONS Phase Forward (Nasdaq:PFWD), a specialist in data management solutions for clinical trials, today...
periodicalarticle
West Coast Editor As promised, Amgen Inc. began dosing patients in two pivotal PhaseIII trials of AMG 162,...
unaggregatedarticle
Staff Writer As its Phase III tesmilifene trial continues to enroll breast cancer patients, YM BioSciences Inc. entered...
unaggregatedarticle
Staff Writer Geron Corp. is bringing in $72 million for ongoing development of its cancer therapies targeting telomerase,...
unaggregatedarticle
Staff Writer CancerVax Corp. is springing back into action as it resumes enrollment in Phase III melanoma studies...
unaggregatedarticle
Washington Editor IDEC Pharmaceuticals Corp.'s stock dipped Tuesday on news that thecompany voluntarily stopped clinical trials of its...
unaggregatedarticle
Staff Writer Just a few weeks after announcing that lead drug DIO-902 significantly reduced cholesterol levels in a...
unaggregatedarticle
Staff Writer Light Sciences Oncology Inc. closed a $30 million Series B financing to support ongoing pivotal trials...
unaggregatedarticle
West Coast Editor Days after raising $65 million in a Series C financing, Somaxon Pharmaceuticals Inc. is kicking...
unaggregatedarticle
Human Genome Sciences Inc and GlaxoSmithKline PLC (GSK) announced that Benlysta (belimumab) met the primary endpoint in BLISS-76,...
unaggregatedarticle
Staff Writer Salmedix Inc. raised $27.5 million in a Series B financing, money it plans to use to...
unaggregatedarticle
BioWorld International Correspondent NeuroSearch's shares crashed more than 40 percent Aug. 10 on news that its lead drug...
unaggregatedarticle
Washington Editor Amgen Inc. said head-to-head studies of Aranesp dosed every two weeks vs. epoetin alfa (or Procrit)...
unaggregatedarticle
Senior Staff Writer On the cusp of its first clinical trials and its largest round of private financing,...
unaggregatedarticle
West Coast Editor A week after disclosing positive Phase II data at ASCO with its topoisomerase II inhibitor...
unaggregatedarticle
The following information was released by the office of the Minister for Innovation, Industry, Science and Research of...
unaggregatedarticle
FULL TEXT Frontline troops will be making a meal of new military ration packs to ensure they are...
unaggregatedarticle
The retrospective subset analysis evaluated the effect of Tysabri on the rate of hospitalization during induction and maintenance...
unaggregatedarticle
BEIJING - After she refused a corrupt cop's demand that she turn her teahouse into an illegal casino,...
unaggregatedarticle
WILMINGTON - The Roman Catholic Diocese of Wilmington filed for bankruptcy protection just hours before eight clergy sex-abuse...
unaggregatedarticle
Oct. 20--WILMINGTON -- The Roman Catholic Diocese of Wilmington filed for bankruptcy protection just hours before eight clergy...
unaggregatedarticle
Courts and Trials: A Reference Handbook, by Christopher Smith. Contemporary World Issues Series. Santa Barbara, CA: ABC-CLIO, 2003....
periodicalarticle
Research and Development ("R&D") activities are an investment field that has become more of an issue in Turkey...
unaggregatedarticle
The following information was released by the National Institutes of Health: A Central Institutional Review Board (CIRB) for...
unaggregatedarticle
- For Non-US Healthcare Media Following the release of linagliptin Phase II data earlier this year, Boehringer Ingelheim...
unaggregatedarticle
This fall, the American Psychiatric Association will begin field trials of the diagnostic criteria and dimensional assessments it...
unaggregatedarticle
This fall, the American Psychiatric Association will begin field trials of the diagnostic criteria and dimensional assessments it...
unaggregatedarticle
NONGTAPAN, Thailand -- Nearly 16,000 Thais ignored the false rumors that they were being infected by the AIDS...
unaggregatedarticle
Byline: Matthew Beard Sports news Correspondent A GROUP of 70 aspiring athletes will tomorrow begin their bid to...
unaggregatedarticle
ImThera Medical, Inc. reported it has received Ethics Committee clearance to begin human clinical trials in Belgium. The...
unaggregatedarticle
Oct. 1--A Charlottesville judge is expected to decide this year if a Richmond man will have two trials...
unaggregatedarticle
ITHACA - Two cancer vaccines developed at Cornell University are now undergoing initial clinical trials. Although called vaccines,...
periodicalarticle
Marking a major milestone in the early detection and management ofcolon cancer, EDP Biotech Corporation (EDP), a developer...
unaggregatedarticle